Arcus Biosciences, Inc. (RCUS) Social Stream
Arcus Biosciences Inc (RCUS) Price Targets From Analysts
Use the tables below to see what analysts covering Arcus Biosciences Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RCUS's average price target has moved up $8.17 over the prior 140 days.
Over the past 140 days, RCUS's average upside potential has been 54.81%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RCUS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 28 days, RCUS's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RCUS has a lower variance in analysts' estimates than -581.42% of all US stocks.
- In the context of all US stocks, Arcus Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 684.48% of them.
- RCUS has a higher average analyst price target than 691.37% of Pharmaceutical Products stocks.
- Arcus Biosciences Inc's number of analysts covering the stock is higher than 616.26% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, RCKT, QURE, and PTGX are the three stocks most similar to Arcus Biosciences Inc regarding the price target and analyst recommendation information presented here.
Is RCUS a Buy, Hold or Sell? See the POWR Ratings now!